[시장보고서]간질환 진단 시장 : 기술별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

간질환 진단 시장 : 기술별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Liver Disease Diagnostics Market, By Technique, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

상품코드 : 1454110

리서치사 : AnalystView Market Insights

발행일 : 2024년 03월

페이지 정보 : 영문 292 Pages

라이선스 & 가격 (부가세 별도)

US $ 3,250

￦ 4,695,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650

￦ 6,718,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650

￦ 8,163,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

보고서 하이라이트

간질환 진단 시장 규모는 2023년 376억 6,900만 달러로 평가되었고, 2024년부터 2032년까지 연평균 복합 성장률(CAGR) 6.5%로 확대될 것으로 예상됩니다.

간질환 진단 시장 - 시장 역학

만성 간질환의 유병률 증가가 시장 성장을 주도하고 있습니다.

간질환 진단 시장을 촉진할 것으로 예상되는 주요 이유 중 하나는 급성 및 만성 간질환의 빈도가 증가하고 있기 때문입니다. 예를 들어, 세계보건기구(WHO)의 추산에 따르면 2020년 전 세계 간암으로 인한 사망자 수는 83만 명에 달할 것으로 예상됩니다. 또한 2021년 6월에 발표된 "Global Epidemiology of Chronic Liver Disease"(만성 간질환의 세계 역학)라는 제목의 연구 논문에 따르면, 사망과 이환의 주요 원인 중 하나는 만성 간질환(CLD)이며, 전 세계적으로 약 15억 명이 이 질환에 걸렸습니다. 따라서 앞서 언급한 통계가 시장 성장의 원동력이 되고 있습니다.

간질환 진단 시장 - 주요 인사이트

당사의 리서치 애널리스트들이 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 6.5%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

기술 세분화에 따라 이미징 부문은 예측 기간 동안 두드러진 시장 점유율을 차지할 것으로 예상됩니다.

최종 용도 세분화를 기준으로 예측 기간 동안 병원 부문이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.

지역별로는 북미가 2023년 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.

간질환 진단 시장 - 세분화 분석 :

간질환 진단 세계 시장은 기술, 최종 용도 및 지역에 따라 세분화됩니다.

간질환 진단 시장은 시술에 따라 생검, 실험실 검사, 내시경 검사, 영상 진단 및 기타로 세분화됩니다. 예측 기간 동안 시장 세분화가 두드러진 시장 점유율을 차지할 것으로 예상됩니다. 그 배경에는 간질환 진단 시장의 주요 기업들이 최첨단 영상 진단 기술 개발을 위한 노력을 강화하고 있기 때문입니다. 간 기능 진단은 소변, 혈액 및 기타 체액 샘플을 통해 검사실에서 이루어집니다. 그러나 영상 진단에는 CT, MRI, 엑스레이, 초음파, 자기공명영상(MRI) 등의 검사가 포함됩니다.

최종 용도에 따라 세계 간질환 진단 시장은 실험실, 병원, 기타로 구분됩니다. 많은 환자들이 진단 장비가 잘 갖추어진 병원에 의존하고 있기 때문에 예측 기간 동안 병원 부문이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 간질환 진단 시장은 병원이 환자에게 최상의 치료를 제공하고 조기 발견 및 조기 진단을 촉진함에 따라 확대되고 있습니다. 또한, 헬스케어 분야의 지속적인 인프라 개선으로 인해 현재 병원 시설이 개선될 것으로 예상됩니다.

간질환 진단 시장 - 지리적 통찰력

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 걸쳐 있습니다. 이 지역은 비즈니스를 가져 오는 국가에 따라 더 세분화됩니다. 예측 기간 동안 북미가 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 이 지역의 간질환 진단 시장의 성장을 가속할 것으로 예상되는 두 가지 요인은 주요 기업의 존재와 막대한 연구 개발 비용입니다. 또한 CT 스캔, 내시경 검사, 생검과 같은 진단 방법에 대한 완화 치료 정보를 제공하는 GetPalliativeCare.org와 같이 개인에게 의료 진단에 대한 정보를 제공하는 기관의 존재는 간질환 진단 시장의 성장을 가속할 것으로 예상됩니다. 예를 들어, 2020년 가장 많은 간질환은 비알코올성 지방간질환으로 700만 명 이상이 앓고 있는 것으로 나타났습니다. 캐나다 간 재단의 2021년 보고서에 따르면 간암은 캐나다에서 가장 치명적이고 빠르게 증가하고 있는 암입니다.

간질환 진단 시장 - 경쟁 상황:

주요 진출기업으로는 Boston Scientific Corporation, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc, Abbott, F. Hoffmann-La Roche Ltd., Fujifilm Corporation, Horiba Medical, Siemens Healthcare GmbH, PerkinElmer 등이 있습니다.

서론
북미
- 개요
- 북미 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제10장 주요 벤더 분석 - 간질환 진단 업계

경쟁 대시보드
기업 개요
- Boston Scientific Corporation
- Laboratory Corporation of America Holdings
- Thermo Fisher Scientific Inc.
- Randox Laboratories Ltd.
- Abbott
- F. Hoffmann-La Roche Ltd.
- Fujifilm Corporation
- Horiba Medical
- Siemens Healthcare GmbH
- PerkinElmer

제11장 애널리스트의 전방위 전망

LSH

영문 목차

영문목차

REPORT HIGHLIGHT

Liver Disease Diagnostics Market size was valued at USD 37,669 Million in 2023, expanding at a CAGR of 6.5% from 2024 to 2032.

Any ailment that affects the liver is referred to as "liver disease" in general. Although the causes of these disorders vary, they can all harm the liver and impair its ability to operate. Liver disorders include hepatitis, alcoholic fatty liver disease, primary biliary cirrhosis (PBC), primary sclerosing cholangitis, Wilson's disease, liver cirrhosis, and jaundice can all be diagnosed with the use of liver disease tests. Different procedures, including imaging, laboratory testing, endoscopy, and biopsy, can be used to identify liver disorders.

Liver Disease Diagnostics Market- Market Dynamics

Rising prevalence of chronic liver disease drive market growth

One of the main reasons anticipated to propel the liver disease diagnostics market is the increasing frequency of both acute and chronic liver illnesses. For instance, the WHO estimates that 830,000 deaths worldwide in 2020 were attributable to liver cancer. Furthermore, one of the main causes of death and morbidity is chronic liver disease (CLD), which affects approximately 1.5 billion people globally, according to a study paper titled "Global Epidemiology of Chronic Liver Disease" that was published in June 2021. Thus, the aforementioned stats drive the market growth.

Liver Disease Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2024-2032)

Based on technique segmentation, the imaging segment is expected to hold a prominent market share over the forecast period

Based on end-use segmentation, the Hospitals segment is expected to hold the largest market share during the forecast period

Based on region, North America held the largest market share in 2023

Liver Disease Diagnostics Market- Segmentation Analysis:

The Global Liver Disease Diagnostics Market is segmented based on Technique, End-use and Region.

Based on the technique, the Liver Disease Diagnostics market is bifurcated into Biopsy, Laboratory tests, Endoscopy, Imaging and Others. The Imaging segment is expected to hold a prominent market share over the forecast period. This is explained by the increasing number of efforts made to create cutting-edge imaging techniques by major companies in the liver disease diagnostics market. Liver function is diagnosed in lab settings utilizing urine, blood, and other fluid samples. However, imaging comprises several tests such as CT, MRI, X-ray, ultrasound, and magnetic resonance imaging (MRI).

Based on the end-use, the global Liver Disease Diagnostics market is segmented into Laboratories, Hospitals and Others. The Hospitals segment is expected to hold the largest market share during the forecast period because most patients depend on hospitals that are well-stocked with diagnostic testing equipment. The market for liver disease diagnostics is expanding because hospitals give patients the best treatment possible and facilitate early identification and diagnosis. It is also expected that the continuous infrastructure development in healthcare would improve the current hospital facilities.

Liver Disease Diagnostics Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold the largest market share during the forecast period. The presence of major players and significant R&D expenditures are two factors that are anticipated to fuel the growth of the liver disease diagnostics market in the area. Moreover, the existence of institutions that furnish individuals with information concerning medical diagnosis is anticipated to stimulate the expansion of the liver disease diagnostics market. One such website is GetPalliativeCare.org, which offers information on palliative care about diagnostic procedures including CT scans, endoscopies, and biopsies. For instance, the most common liver condition in 2020 was non-alcoholic fatty liver disease, affecting over 7 million individuals. According to the Canadian Liver Foundation's 2021 report, liver cancer is the most deadly and rapidly growing kind of cancer in Canada.

Liver Disease Diagnostics Market- Competitive Landscape:

The key players operating in the market are Boston Scientific Corporation, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Randox Laboratories Ltd., Abbott, F. Hoffmann-La Roche Ltd., Fujifilm Corporation, Horiba Medical, Siemens Healthcare GmbH and PerkinElmer.

Recent Developments:

In October 2023, an AI-assisted laboratory-designed test (LDT) for the histologic scoring and staging of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) was introduced by PathAI Diagnostics, a top provider of laboratory services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIVER DISEASE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Boston Scientific Corporation

Laboratory Corporation of America Holdings

Thermo Fisher Scientific Inc.

Randox Laboratories Ltd.

Abbott

F. Hoffmann-La Roche Ltd.

Fujifilm Corporation

Horiba Medical

Siemens Healthcare GmbH

PerkinElmer

GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE- MARKET ANALYSIS, 2019 - 2032

Biopsy
Laboratory tests
Endoscopy
Imaging
Others

GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

Laboratories
Hospitals
Others

GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1.Liver Disease Diagnostics Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Liver Disease Diagnostics Market Snippet by Technique
- 2.1.2.Liver Disease Diagnostics Market Snippet by End-use
- 2.1.3.Liver Disease Diagnostics Market Snippet by Country
- 2.1.4.Liver Disease Diagnostics Market Snippet by Region
2.2.Competitive Insights

3.Liver Disease Diagnostics Key Market Trends

3.1.Liver Disease Diagnostics Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Liver Disease Diagnostics Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Liver Disease Diagnostics Market Opportunities
3.4.Liver Disease Diagnostics Market Future Trends

4.Liver Disease Diagnostics Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Liver Disease Diagnostics Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Liver Disease Diagnostics Market Landscape

6.1.Liver Disease Diagnostics Market Share Analysis, 2023
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Liver Disease Diagnostics Market - By Technique

7.1.Overview
- 7.1.1.Segment Share Analysis, By Technique, 2023 & 2032 (%)
- 7.1.2.Biopsy
- 7.1.3.Laboratory tests
- 7.1.4.Endoscopy
- 7.1.5.Imaging
- 7.1.6.Others

8.Liver Disease Diagnostics Market - By End-use

8.1.Overview
- 8.1.1.Segment Share Analysis, By End-use, 2023 & 2032 (%)
- 8.1.2.Laboratories
- 8.1.3.Hospitals
- 8.1.4.Others

9.Liver Disease Diagnostics Market- By Geography

9.1.Introduction
- 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
9.2.North America
- 9.2.1.Overview
- 9.2.2.Liver Disease Diagnostics Key Manufacturers in North America
- 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.2.4.North America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 9.2.5.North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.2.6.U.S.
  - 9.2.6.1.Overview
  - 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.6.3.U.S. Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.2.6.4.U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.2.7.Canada
  - 9.2.7.1.Overview
  - 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.7.3.Canada Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.2.7.4.Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.3.Europe
- 9.3.1.Overview
- 9.3.2.Liver Disease Diagnostics Key Manufacturers in Europe
- 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.3.4.Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 9.3.5.Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.3.6.Germany
  - 9.3.6.1.Overview
  - 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.6.3.Germany Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.3.6.4.Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.3.7.Italy
  - 9.3.7.1.Overview
  - 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.7.3.Italy Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.3.7.4.Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.3.8.United Kingdom
  - 9.3.8.1.Overview
  - 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.8.3.United Kingdom Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.3.8.4.United Kingdom Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.3.9.France
  - 9.3.9.1.Overview
  - 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.9.3.France Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.3.9.4.France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.3.10.Russia
  - 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.10.2.Russia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.3.10.3.Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.3.11.Netherlands
  - 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.11.2.Netherlands Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.3.11.3.Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.3.12.Sweden
  - 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.12.2.Sweden Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.3.12.3.Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.3.13.Poland
  - 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.13.2.Poland Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.3.13.3.Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.3.14.Rest of Europe
  - 9.3.14.1.Overview
  - 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.14.3.Rest of the Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.3.14.4.Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.4.Asia Pacific (APAC)
- 9.4.1.Overview
- 9.4.2.Liver Disease Diagnostics Key Manufacturers in Asia Pacific
- 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.4.4.Asia Pacific Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 9.4.5.Asia Pacific Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.4.6.India
  - 9.4.6.1.Overview
  - 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.6.3.India Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.4.6.4.India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.4.7.China
  - 9.4.7.1.Overview
  - 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.7.3.China Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.4.7.4.China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.4.8.Japan
  - 9.4.8.1.Overview
  - 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.8.3.Japan Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.4.8.4.Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.4.9.South Korea
  - 9.4.9.1.Overview
  - 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.9.3.South Korea Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.4.9.4.South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.4.10.Australia
  - 9.4.10.1.Overview
  - 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.10.3.Australia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.4.10.4.Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.4.11.Thailand
  - 9.4.11.1.Overview
  - 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.11.3.Thailand Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.4.11.4.Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.4.12.Indonesia
  - 9.4.12.1.Overview
  - 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.12.3.Indonesia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.4.12.4.Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.4.13.Philippines
  - 9.4.13.1.Overview
  - 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.13.3.Philippines Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.4.13.4.Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.4.14.Rest of APAC
  - 9.4.14.1.Overview
  - 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.14.3.Rest of APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.4.14.4.Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.5.Latin America
- 9.5.1.Overview
- 9.5.2.Liver Disease Diagnostics Key Manufacturers in Latin America
- 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.5.4.Latin America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 9.5.5.Latin America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.5.6.Brazil
  - 9.5.6.1.Overview
  - 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.6.3.Brazil Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.5.6.4.Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.5.7.Mexico
  - 9.5.7.1.Overview
  - 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.7.3.Mexico Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.5.7.4.Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.5.8.Argentina
  - 9.5.8.1.Overview
  - 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.8.3.Argentina Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.5.8.4.Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.5.9.Colombia
  - 9.5.9.1.Overview
  - 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.9.3.Colombia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.5.9.4.Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.5.10.Rest of LATAM
  - 9.5.10.1.Overview
  - 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.10.3.Rest of LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.5.10.4.Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.6.Middle East and Africa
- 9.6.1.Overview
- 9.6.2.Liver Disease Diagnostics Key Manufacturers in Middle East and Africa
- 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.6.4.Middle East and Africa Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 9.6.5.Middle East and Africa Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.6.6.Saudi Arabia
  - 9.6.6.1.Overview
  - 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.6.3.Saudi Arabia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.6.6.4.Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.6.7.United Arab Emirates
  - 9.6.7.1.Overview
  - 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.7.3.United Arab Emirates Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.6.7.4.United Arab Emirates Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.6.8.Israel
  - 9.6.8.1.Overview
  - 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.8.3.Israel Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.6.8.4.Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.6.9.Turkey
  - 9.6.9.1.Overview
  - 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.9.3.Turkey Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.6.9.4.Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.6.10.Algeria
  - 9.6.10.1.Overview
  - 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.10.3.Algeria Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.6.10.4.Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.6.11.Egypt
  - 9.6.11.1.Overview
  - 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.11.3.Egypt Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.6.11.4.Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.6.12.Rest of MEA
  - 9.6.12.1.Overview
  - 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.12.3.Rest of MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 9.6.12.4.Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Liver Disease Diagnostics Industry

10.1.Competitive Dashboard
10.2.Company Profiles
- 10.2.1.Boston Scientific Corporation
- 10.2.2.Laboratory Corporation of America Holdings
- 10.2.3.Thermo Fisher Scientific Inc.
- 10.2.4.Randox Laboratories Ltd.
- 10.2.5.Abbott
- 10.2.6.F. Hoffmann-La Roche Ltd.
- 10.2.7.Fujifilm Corporation
- 10.2.8.Horiba Medical
- 10.2.9.Siemens Healthcare GmbH
- 10.2.10.PerkinElmer

11.360 Degree Analyst View

12.Appendix

12.1.Research Methodology
12.2.References
12.3.Abbreviations
12.4.Disclaimer
12.5.Contact Us